SAB Biotherapeutics Warrant
SABSW
SABSW
10 hedge funds and large institutions have $19.5K invested in SAB Biotherapeutics Warrant in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
10
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$750 | |
| 2 | +$539 | |
| 3 | +$5 | |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$5 |
| 5 |
CS
Clear Street
New York
|
+$5 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LP
1
LMR Partners
London,
United Kingdom
| $12.6K |
|
|||
2
Morgan Stanley
New York
| $3.43K |
|
|||
|
CS
3
Clear Street
New York
| $1.85K |
|
|||
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $750 |
|
|||
5
UBS Group
Zurich,
Switzerland
| $539 |
|
|||
6
Walleye Trading
New York
| $268 |
|
|||
|
WAM
7
Wolverine Asset Management
Chicago,
Illinois
| $42 |
|
|||
|
NA
8
NewEdge Advisors
New Orleans,
Louisiana
| $25 |
|
|||
9
Bank of America
Charlotte,
North Carolina
| $5 |
|
|||
|
10
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $5 |
|